FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 354:1-3 January 5, 2006 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Interview Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

On October 5, 2005, the U.S. Supreme Court heard oral arguments in Gonzales v. Oregon. On the surface, this case is about the legitimacy of physicians' prescribing of medications under Oregon's Death with Dignity Act and whether the federal government can overrule the states in defining "legitimate medical practice." Just beneath the surface, however, lies the risk of empowering agents of the Drug Enforcement Agency (DEA) — whose traditional role is to prevent drug abuse and diversion — to evaluate the end-of-life practices of physicians whose patients die while receiving prescribed opioids or barbiturates. A finding in favor of . . . [Full Text of this Article]

Source Information

Dr. Quill is a professor of medicine, psychiatry, and medical humanities and the director of the Center for Palliative Care and Clinical Ethics at the University of Rochester School of Medicine, Rochester, N.Y.; Dr. Meier is a professor of geriatrics, medicine, and medical ethics and the director of the Lilian and Benjamin Hertzberg Palliative Care Institute and the Center to Advance Palliative Care at the Mount Sinai School of Medicine, New York.

An interview with Dr. Quill and Dr. Meier can be heard at www.nejm.org.

This article has been cited by other articles:

• Imhof, S., Kaskie, B. (2008). How Can We Make the Pain Go Away? Public Policies to Manage Pain at the End of Life. Gerontologist 48: 423-431 [Abstract] [Full Text]  
• Cohen, A. L., Bhatnagar, J., Reagan, S., Zane, S. B., D'Angeli, M. A., Fischer, M., Killgore, G., Kwan-Gett, T. S., Blossom, D. B., Shieh, W.-J., Guarner, J., Jernigan, J., Duchin, J. S., Zaki, S. R., McDonald, L. C. (2007). Toxic Shock Associated With Clostridium sordellii and Clostridium perfringens After Medical and Spontaneous Abortion. Obstet Gynecol 110: 1027-1033 [Abstract] [Full Text]  
• Nava, S., Sturani, C., Hartl, S., Magni, G., Ciontu, M., Corrado, A., Simonds, A., on behalf of the European Respiratory Society Task, (2007). End-of-life decision-making in respiratory intermediate care units: a European survey. Eur Respir J 30: 156-164 [Abstract] [Full Text]  
• Andrade, L., Cleto, S., Seguro, A. C. (2007). Door-to-Dialysis Time and Daily Hemodialysis in Patients with Leptospirosis: Impact on Mortality. CJASN 2: 739-744 [Abstract] [Full Text]  
• Johnson, S. G., Witt, D. M., Eddy, T. R., Delate, T., for the Clinical Pharmacy Anticoagulation Service, (2007). Warfarin and Antiplatelet Combination Use Among Commercially Insured Patients Enrolled in an Anticoagulation Management Service. Chest 131: 1500-1507 [Abstract] [Full Text]  
• Edwards, K. L., Hall, R. G., Ceja, M. E. (2007). Gatifloxacin-Induced Hyperglycemia: A Review of 4 Cases and the Literature. Journal of Pharmacy Practice 20: 93-102 [Abstract]  
• Williams, B. (2006). The Year in Hypertension. J Am Coll Cardiol 48: 1698-1711 [Full Text]  
• Legant, P. (2006). Oncologists and Medical Malpractice. J Oncol Pract 2: 164-169 [Full Text]  
• Annas, G. J. (2006). Congress, Controlled Substances, and Physician-Assisted Suicide -- Elephants in Mouseholes. NEJM 354: 1079-1084 [Full Text]